A detailed history of Benjamin Edwards Inc transactions in Viatris Inc stock. As of the latest transaction made, Benjamin Edwards Inc holds 65,372 shares of VTRS stock, worth $849,836. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,372
Holding current value
$849,836
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $674,639 - $792,962
65,372 New
65,372 $758,000
Q1 2023

Apr 27, 2023

SELL
$9.2 - $12.26 $524 - $698
-57 Reduced 77.03%
17 $0
Q4 2022

Feb 07, 2023

SELL
$8.72 - $11.56 $17 - $23
-2 Reduced 2.63%
74 $1,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $139 - $171
-14 Reduced 15.56%
76 $1,000
Q1 2022

May 04, 2022

SELL
$9.81 - $15.4 $1,393 - $2,186
-142 Reduced 61.21%
90 $1,000
Q4 2021

Feb 07, 2022

BUY
$12.09 - $14.68 $447 - $543
37 Added 18.97%
232 $3,000
Q3 2021

Nov 02, 2021

BUY
$13.25 - $15.13 $2,583 - $2,950
195 New
195 $3,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.